224 related articles for article (PubMed ID: 30773756)
21. Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring.
Pettus J; Edelman SV
Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S234-42. PubMed ID: 26784128
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial.
Wan W; Skandari MR; Minc A; Nathan AG; Winn A; Zarei P; O'Grady M; Huang ES
Diabetes Care; 2018 Jun; 41(6):1227-1234. PubMed ID: 29650803
[TBL] [Abstract][Full Text] [Related]
23. An online failure detection method of the glucose sensor-insulin pump system: improved overnight safety of type-1 diabetic subjects.
Facchinetti A; Del Favero S; Sparacino G; Cobelli C
IEEE Trans Biomed Eng; 2013 Feb; 60(2):406-16. PubMed ID: 23193300
[TBL] [Abstract][Full Text] [Related]
24. [Current status of continuous subcutaneous insulin infusion and continuous glucose monitoring systems in the Community of Madrid].
Arranz Martín A; Calle Pascual A; Del Cañizo Gómez FJ; González Albarrán O; Lisbona Gil A; Botella Serrano M; Pallardo Sánchez LF;
Endocrinol Nutr; 2015 Apr; 62(4):171-9. PubMed ID: 25726367
[TBL] [Abstract][Full Text] [Related]
25. Insulin Sensitivity Index-Based Optimization of Insulin to Carbohydrate Ratio: In Silico Study Shows Efficacious Protection Against Hypoglycemic Events Caused by Suboptimal Therapy.
Schiavon M; Dalla Man C; Cobelli C
Diabetes Technol Ther; 2018 Feb; 20(2):98-105. PubMed ID: 29355438
[TBL] [Abstract][Full Text] [Related]
26. Use of insulin pumps and closed-loop systems among people living with diabetes: A narrative review of clinical and cost-effectiveness to enable access to technology and meet the needs of payers.
Jendle J; Reznik Y
Diabetes Obes Metab; 2023 Jul; 25 Suppl 2():21-32. PubMed ID: 37046364
[TBL] [Abstract][Full Text] [Related]
27. Diabetes Technological Revolution: Winners and Losers?
Barnard KD; Breton MD
J Diabetes Sci Technol; 2018 Nov; 12(6):1227-1230. PubMed ID: 30035611
[TBL] [Abstract][Full Text] [Related]
28. Costs of treatment and complications of adult type 1 diabetes.
Franciosi M; Lucisano G; Amoretti R; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Vitacolonna E; Nicolucci A
Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):606-11. PubMed ID: 22749531
[TBL] [Abstract][Full Text] [Related]
29. Reimbursement for continuous glucose monitoring: a European view.
Heinemann L; Franc S; Phillip M; Battelino T; Ampudia-Blasco FJ; Bolinder J; Diem P; Pickup J; Hans Devries J
J Diabetes Sci Technol; 2012 Nov; 6(6):1498-502. PubMed ID: 23294797
[TBL] [Abstract][Full Text] [Related]
30. Event and Cost Offsets of Switching 20% of the Type 1 Diabetes Population in Germany From Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion: A 4-Year Simulation Model.
Zöllner YF; Ziegler R; Stüve M; Krumreich J; Schauf M
J Diabetes Sci Technol; 2016 Sep; 10(5):1142-8. PubMed ID: 26902790
[TBL] [Abstract][Full Text] [Related]
31. Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the ČENDA registry.
Šumník Z; Pavlíková M; Pomahačová R; Venháčová P; Petruželková L; Škvor J; Neumann D; Vosáhlo J; Konečná P; Čížek J; Strnadel J; Průhová Š; Cinek O;
Pediatr Diabetes; 2021 May; 22(3):439-447. PubMed ID: 33533545
[TBL] [Abstract][Full Text] [Related]
32. High frequencies of dermatological complications in children using insulin pumps or sensors.
Berg AK; Olsen BS; Thyssen JP; Zachariae C; Simonsen AB; Pilgaard K; Svensson J
Pediatr Diabetes; 2018 Jun; 19(4):733-740. PubMed ID: 29484783
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.
Rigo RS; Levin LE; Belsito DV; Garzon MC; Gandica R; Williams KM
J Diabetes Sci Technol; 2021 Jul; 15(4):786-791. PubMed ID: 32389062
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in management of type 1 diabetes.
Pyrlis F; Brown F; Ekinci EI
Aust J Gen Pract; 2019 May; 48(5):256-261. PubMed ID: 31129934
[TBL] [Abstract][Full Text] [Related]
35. Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment.
Hellmund R; Weitgasser R; Blissett D
Diabetes Res Clin Pract; 2018 Apr; 138():193-200. PubMed ID: 29410149
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
37. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
Olsen B; Johannesen J; Fredheim S; Svensson J;
Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
[TBL] [Abstract][Full Text] [Related]
38. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
[TBL] [Abstract][Full Text] [Related]
39. Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes.
Kravarusic J; Aleppo G
Endocrinol Metab Clin North Am; 2020 Mar; 49(1):37-55. PubMed ID: 31980120
[TBL] [Abstract][Full Text] [Related]
40. Automated Insulin Delivery in Children with Type 1 Diabetes.
Cengiz E
Endocrinol Metab Clin North Am; 2020 Mar; 49(1):157-166. PubMed ID: 31980115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
